Search Results for "imiquimod"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for imiquimod. Results 11 to 13 of 13 total matches.
See also: Aldara, Zyclara

Drugs for Sexually Transmitted Infections

   
The Medical Letter on Drugs and Therapeutics • Jun 27, 2022  (Issue 1653)
mg-1 g PO once/day36 Famciclovir 250 mg PO bid Anogenital Warts37 Patient-applied Imiquimod 3.75 ...
This article includes recommendations for management of most sexually transmitted infections (STIs) other than HIV and viral hepatitis. Some of the indications and dosages recommended here have not been approved by the FDA (see Table 1).
Med Lett Drugs Ther. 2022 Jun 27;64(1653):97-104 |  Show IntroductionHide Introduction

Antiviral Drugs for Varicella-Zoster Virus and Herpes Simplex Virus Infections

   
The Medical Letter on Drugs and Therapeutics • Sep 24, 2018  (Issue 1556)
such as rash and pruritus. Imiquimod cream (Zyclara, and others) and cidofovir gel, which must be compounded ...
The recommendations for treatment of varicella-zoster virus (VZV) and herpes simplex virus (HSV) infections are listed in tables 1 and 2. Vaccination against VZV was reviewed in a previous issue.
Med Lett Drugs Ther. 2018 Sep 24;60(1556):153-7 |  Show IntroductionHide Introduction

Cantharidin Topical Solution (Ycanth) for Molluscum Contagiosum

   
The Medical Letter on Drugs and Therapeutics • Feb 19, 2024  (Issue 1696)
, and imiquimod cream. Cryotherapy, curettage, and pulsed dye laser treatment have also been used.1 MECHANISM ...
The FDA has approved cantharidin 0.7% solution (Ycanth – Verrica) for topical treatment of molluscum contagiosum in patients ≥2 years old. Ycanth was the first drug to be approved in the US for this indication. A 10.3% gel formulation of berdazimer (Zelsuvmi), a nitric oxide-releasing agent, has also been approved by the FDA for treatment of molluscum contagiosum (in patients ≥1 year old); it will be reviewed in a future issue.
Med Lett Drugs Ther. 2024 Feb 19;66(1696):27-9   doi:10.58347/tml.2024.1696b |  Show IntroductionHide Introduction